What is the most recent earnings date for ABOS stock?
ACUMEN PHARMACEUTICALS INC (ABOS) last reported earnings on 3/26/2026.
ACUMEN PHARMACEUTICALS INC (ABOS) Earnings History & Surprises
NASDAQ:ABOS • US00509G2093
Current stock price
2.73 USD
-0.11 (-3.87%)
At close:
2.78 USD
+0.05 (+1.83%)
After Hours:
ABOS Earnings overview
Past quarterly earnings results for ACUMEN PHARMACEUTICALS INC (ABOS), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 11, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.41
- Revenue Estimate
Last Reported
Most Recent- Release Date
- Mar 26, 2026
- Period
- Q4 / 2025
- EPS Reported
- -$0.41
- EPS Surprise
- 11.30%
- Revenue Surprise
- %
Beat Rate
Last 8 Quarters 25%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.41 | -0.46 | 11.30% | 33.87% | - | - | ||
| Q3 2025 | -0.44 | -0.62 | 28.53% | 12.00% | - | - | ||
| Q2 2025 | -0.68 | -0.55 | -23.92% | -100.00% | - | - | ||
| Q1 2025 | -0.48 | -0.68 | 29.06% | -92.00% | - | - | ||
| Q4 2024 | -0.62 | -0.49 | -26.63% | -121.43% | - | - | ||
| Q3 2024 | -0.50 | -0.37 | -34.30% | -108.33% | - | - | ||
| Q2 2024 | -0.34 | -0.29 | -19.05% | -21.43% | - | - | ||
| Q1 2024 | -0.25 | -0.27 | 5.73% | 10.71% | - | - | ||
| Q4 2023 | -0.28 | -0.27 | -5.58% | 12.50% | - | - | ||
| Q3 2023 | -0.24 | -0.27 | 11.54% | 7.69% | - | - | ||
| Q2 2023 | -0.28 | -0.35 | 20.66% | -12.00% | - | - | ||
| Q1 2023 | -0.28 | -0.35 | 20.66% | -21.74% | - | - | ||
| Q4 2022 | -0.32 | -0.26 | -22.84% | 23.08% | - | - | ||
| Q3 2022 | -0.26 | -0.23 | -10.92% | -160.00% | - | - | ||
| Q2 2022 | -0.25 | -0.25 | -0.04% | 96.84% | - | - | ||
| Q1 2022 | -0.23 | -0.17 | -35.84% | - | - | - | ||
| Q4 2021 | -0.42 | -0.14 | -187.21% | - | - | -100.00% | ||
| Q3 2021 | -0.10 | -0.17 | 42.44% | - | - | -100.00% | ||
| Q2 2021 | -7.91 | -4.65 | -70.21% | - | - | -100.00% | ||
| Q1 2021 | - | - | - | -100.00% | ||||
| Q4 2020 | - | - | 330K | - | - | |||
| Q3 2020 | - | - | 730K | - | - | |||
| Q2 2020 | - | - | 150K | - | - | |||
| Q1 2020 | - | - | 230K | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
3
Average EPS beat (4)
11.24%
Max EPS beat (4)
29.06%
Min EPS beat (4)
-23.92%
Revenue beat statistics
Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A
Analysis
In the last 4 quarters, ABOS has beaten EPS estimates in 3 out of 4 releases
In the last 4 quarters, ABOS has beaten the EPS estimates by 11.2% on average.
Related analysis
ACUMEN PHARMACEUTICALS INC / ABOS Earnings FAQ
Did ACUMEN PHARMACEUTICALS INC (ABOS) beat earnings estimates last quarter?
ACUMEN PHARMACEUTICALS INC (ABOS) beat EPS estimates and missed revenue estimates in the most recent quarter.
How often does ACUMEN PHARMACEUTICALS INC (ABOS) beat earnings estimates?
In the last 4 quarters, ACUMEN PHARMACEUTICALS INC (ABOS) has beaten EPS estimates in 3 out of 4 releases.